US Patent Issued to Talengen International on March 17 for "Method and drug for treating spinal muscular atrophy" (Chinese Inventor)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,139, issued on March 17, was assigned to Talengen International Ltd. (Hong Kong).

"Method and drug for treating spinal muscular atrophy" was invented by Jinan Li (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a method for treating spinal muscular atrophy (SMA), comprising: administrating a therapeutically effective amount of a plasminogen pathway activator to a subject. Further provided are a pharmaceutical composition, product and kit comprising said plasminogen pathway activator, which are used for treating spinal muscular atrophy."

The patent was filed on Nov. 17, 2020, under Application No. 17/924,617.

*For further inform...